Clinical Trials

Showing trials with last updates posted in 2015.

NCT00754494 | COMPLETED | PHASE2
45 participants

Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma

Study Type:
INTERVENTIONAL
Last Updated:
2015-01-06
Start Date:
2008-07-31
Completion:
2012-10-31
Conditions
  • Adenomatous Polyp
  • Recurrent Colon Cancer
  • Recurrent Rectal Cancer
  • Stage I Colon Cancer
  • Stage I Rectal Cancer
  • Stage IIA Colon Cancer
  • Stage IIA Rectal Cancer
  • Stage IIB Colon Cancer
  • Stage IIB Rectal Cancer
  • Stage IIC Colon Cancer
  • Stage IIC Rectal Cancer
  • Stage IIIA Colon Cancer
  • Stage IIIA Rectal Cancer
  • Stage IIIB Colon Cancer
  • Stage IIIB Rectal Cancer
  • Stage IIIC Colon Cancer
  • Stage IIIC Rectal Cancer
Interventions
  • DRUG
  • OTHER
NCT00381550 | COMPLETED | PHASE2
35 participants

3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2015-01-06
Start Date:
2006-08-31
Completion:
2011-03-31
Conditions
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • Blastic Phase Chronic Myelogenous Leukemia
  • Chronic Eosinophilic Leukemia
  • Chronic Myelomonocytic Leukemia
  • Essential Thrombocythemia
  • Philadelphia Chromosome Negative Chronic Myelogenous Leukemia
  • Polycythemia Vera
  • Primary Myelofibrosis
  • Relapsing Chronic Myelogenous Leukemia
Interventions
  • DRUG
  • PROCEDURE
Previous
Sorted by latest updates
Next
Showing 40 trials per page